» Articles » PMID: 37529003

Three-dimensional Mesenchymal Stem Cell Laden Scaffold of Icariin Sustained-release for Bone Regeneration

Overview
Journal Turk J Biol
Specialty Biology
Date 2023 Aug 2
PMID 37529003
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aim: Icariin (ICA)-loaded zein/PLGA nanofiber membrane combined with MSCs was prepared by coaxial electrospinning and bioelectrospraying.

Materials And Methods: SEM and TEM were used to evaluate the surface morphology and microstructure of the fiber membrane. Ultraviolet spectrophotometry was used to detect drug release. A LIVE/DEAD Viability/Cytotoxicity Kit and fluorescence staining were used to detect cell morphology and activity. Alkaline phosphatase and calcium mineralization deposition were used to evaluate the osteoinductive activity of the scaffold. Dynamic mechanical analysis was used to determine the Young's modulus, maximum load, and maximum elongation of the prepared scaffold. Western blot was used to detect the related protein expression in MSCs induced by drug-loaded scaffolds.

Results: Good mechanical properties and stability were observed in the prepared drug-loaded scaffolds. SEM showed that there were a considerable number of MSCs dispersed in the scaffold. MSCs were evenly distributed, could grow evenly between fibers, and were arranged orderly along the fibers. Sustained release of ICA confers cell laden scaffold higher ALP activity and ECM mineral deposition through Runx2, OPN and OCN pathways.

Conclusion: Isotropic sustained release of ICA grant cell laden scaffolds rapid bone regeneration compacity which can provide a good osteogenic environment for loaded MSCs.

Citing Articles

Effect of icariin on ovarian cancer: a combined network pharmacology and meta-analysis of studies approach.

Cao S, Chen B, Zou Z, Yang S, Fu X Front Pharmacol. 2025; 15:1418111.

PMID: 39759453 PMC: 11695863. DOI: 10.3389/fphar.2024.1418111.


Promoting osteogenesis and bone regeneration employing icariin-loaded nanoplatforms.

Mohammadzadeh M, Zarei M, Abbasi H, Webster T, Beheshtizadeh N J Biol Eng. 2024; 18(1):29.

PMID: 38649969 PMC: 11036660. DOI: 10.1186/s13036-024-00425-4.

References
1.
Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

2.
Lima A, Ferreira H, Reis R, Neves N . Biodegradable polymers: an update on drug delivery in bone and cartilage diseases. Expert Opin Drug Deliv. 2019; 16(8):795-813. DOI: 10.1080/17425247.2019.1635117. View

3.
Zou L, Kidwai F, Kopher R, Motl J, Kellum C, Westendorf J . Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells. Stem Cell Reports. 2015; 4(2):190-8. PMC: 4325195. DOI: 10.1016/j.stemcr.2015.01.008. View

4.
Gokcinar-Yagci B, Uckan-Cetinkaya D, Celebi-Saltik B . Pericytes: Properties, Functions and Applications in Tissue Engineering. Stem Cell Rev Rep. 2015; 11(4):549-59. DOI: 10.1007/s12015-015-9590-z. View

5.
Bielby R, Jones E, McGonagle D . The role of mesenchymal stem cells in maintenance and repair of bone. Injury. 2007; 38 Suppl 1:S26-32. DOI: 10.1016/j.injury.2007.02.007. View